![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, January 26, 2014 7:23:44 PM
Thanks for the nice note, so sorry to see the degree cancer has impacted your family/loved ones. It certainly reaffirms the need to stay well read on new developments/research in the oncology arena. I know I try to be well read due to my daughter but fortunately she is as well since she is a nurse. As for our current Kevetrin trial, I am hopeful we get a similar update at this years ASCO as we did last year. Imagine if they can report multiple patients with "tumor regression" by that juncture since additional cohort information will be available. That will open eyes for sure. I also agree the fact that the Univ. of Bologna is moving forward with their study prior to completion of the Phase I at DF speaks volume since it appears they feel they have enough information now so why wait (plus they probably have access to additional info).
One other point I wanted to toss out to the forum here concerns the potential for some of the other assets Cellceutix acquired in the Polymedix fire sale such as the PolyCide Antimicrobial in Surgical Suture Coatings application. The link below shows it had very favorable results in their study. I have been unable to determine what the market might be for this application. Thoughts anyone..... The use of antimicrobial coating technology on other surfaces also is of interest to me since my profession (industrial hygiene/health and safety) takes me in to hospital settings where hospital acquired/nosocomial infections are a big problem. The fruition of this type application/technology may be many years away but imagine developing surfaces that inhibit microbial contamination, the applications, and inmplications are vast.....
http://globenewswire.com/news-release/2012/09/05/488925/10004018/en/Data-Showing-Effectiveness-of-PolyCide-Antimicrobial-in-Surgical-Suture-Coatings-Published-in-American-Chemical-Society-Journal-Langmuir.html
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM